Intraperitoneal administration of the globular adiponectin gene ameliorates diabetic nephropathy in Wistar rats

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2293-2300

  Yuan, Fang ^a   Liu, Ying Hong ^a   Liu, Fu You ^a   Peng, You Ming ^a   Tian, Jun Wei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adenosine monophosphate activated protein kinase; Adiponectin; Diabetic nephropathy; Endothelial nitric oxide synthase; Transforming growth factor 1; Urine albumin

Indexed keywords

ADIPONECTIN; ALBUMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENHANCED GREEN FLUORESCENT PROTEIN; GENE THERAPY AGENT; GLOBULAR PROTEIN; LIPOFECTAMINE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FIBROSING ALVEOLITIS; GAD GENE; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECOMBINANT PLASMID; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; URINE LEVEL; WESTERN BLOTTING; WISTAR RAT; ANIMAL; BLOOD; DIABETIC NEPHROPATHIES; DISEASE MODEL; GENETIC TRANSFECTION; GENETICS; GLOMERULUS; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; MESANGIUM; METABOLISM; PATHOLOGY; PROTEINURIA; REPORTER GENE; URINE;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENES, REPORTER; GLOMERULAR MESANGIUM; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY GLOMERULUS; MALE; NITRIC OXIDE SYNTHASE TYPE III; PROTEINURIA; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84899695173     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2133     Document Type: Article

References (20)

1. Stojiljkovic L and Behnia R: Role of renin angiotensin system inhibitors in cardiovascular and renal protection: a lesson from clinical trials. Curr Pharm Des 13: 1335-1345, 2007. (Pubitemid 46746371)
2. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000. (Pubitemid 30353893)
3. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, et al: Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88: 3236-3240, 2003. (Pubitemid 36877499)
4. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999. (Pubitemid 29299050)
5. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360: 57-58, 2002. (Pubitemid 34756495)
6. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23: 85-89, 2003. (Pubitemid 36091630)
7. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F and Matsuzawa Y: Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16: 72-75, 2003. (Pubitemid 36078595)
8. Holst JJ and Binderup M: Fatty tissue and insulin resistance: resistin and adiponectin. Ugeskr Laeger 164: 2173-2176, 2002 (In Danish). (Pubitemid 34414077)
9. Lin J, Hu FB and Curhan G: Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care 30: 239-244, 2007. (Pubitemid 46198325)
10. Koshimura J, Fujita H, Narita T, et al: Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 316: 165-169, 2004. (Pubitemid 38299140)
11. Saito T, Saito O, Kawano T, et al: Elevation of serum adiponectin and CD146 levels in diabetic nephropathy. Diabetes Res Clin 78: 85-92, 2007. (Pubitemid 47348153)
12. Sharma K, Ramachandrarao S, Qiu G, et al: Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118: 1645-1656, 2008. (Pubitemid 351632369)
13. Guo X, Liu Z, Li H, et al: A novel rat model of type 2 diabetes mellitus. Chinese Journal of Nephrology Dialysis & Transplantation 9: 351-355, 2000.
14. Adamczak M, Chudek J and Wiecek A: Adiponectin in patients with chronic kidney disease. Semin Dial 22: 391-395, 2009.
15. Bhatia S, Shukla R, Venkata Madhu S, et al: Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 36: 557-562, 2003. (Pubitemid 37244019)
16. Obrosova IG, Fathallah L, Liu E, et al: Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid. Free Radic Biol Med 34: 186-195, 2003. (Pubitemid 36084322)
17. Park IS, Kiyomoto H, Abboud SL, et al: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46: 473-480, 1997. (Pubitemid 27090278)
18. Wahab NA, Harper K and Mason RM: Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycemia. Biochem J 316: 985-992, 1996. (Pubitemid 26278453)
19. Yuan F, Liu F, Liu YH, et al: Effect of adiponectin on reactive oxygen species and endothelial nitric oxide synthase expression induced by high glucose in human mesangial cells. Chin J Nephrol 9: 725-727, 2009.
20. Yamauchi T, Kamom J, Ito Y, et al: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003. (Pubitemid 36735700)